Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Vascular Dementia: early-phase trial registry

5 of 11 indexed Vascular Dementia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 5 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Vascular Dementia: 11 US clinical trials tracked, 5 recruiting.

Vascular Dementia is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition vascular-dementia

OPEN 5 | RECR 45% | LATE 1 | EARLY 2 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Breast Carcinoma (45% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Vascular Dementia (this)45%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Vascular Dementia

Vascular Dementia lists 5 open slots (45% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vascular Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vascular Dementia recruits in line with its size-band peers.

    5 of 11 indexed trials (45.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vascular Dementia research.

    Mayo Clinic accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vascular Dementia enrolment sits around 120 participants.

    Median target enrolment is 120 among the 11 trials that report a genuine target (sentinel values excluded). 5 of those (45.5%) plan for fewer than 100 participants.

  4. Vascular Dementia splits between interventional and observational designs.

    6 interventional and 5 observational studies make up this index (54.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 31

Open and recent trials

11 total, page 1 of 1

RECRUITING 10,000 participants

Longitudinal Cognitive Assessment by BoCA

Alzheimer's Light

NCT04114994

RECRUITING 375 participants

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Center for Clinical Studies, Texas

NCT06903078

RECRUITING 300 participants

Cognitive and Vascular Functioning Following TBI

Walter Reed National Military Medical Center

NCT06034509

RECRUITING NA 120 participants

The BRAIN App (Phase 2 SBIR)

Hopeful Aging

NCT06298474

RECRUITING NA 48 participants

Pulsed Electromagnetic Field Treatment With Dementia Patients

Herrick Medical

NCT06862557

ACTIVE NOT RECRUITING 72 participants

Florida Cerebrovascular Disease Biorepository and Genomics Center

Mayo Clinic

NCT05491980

COMPLETED Phase 3 708 participants

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Novartis Pharmaceuticals

NCT00099216

COMPLETED 204 participants

NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)

Pamlab

NCT01370954

COMPLETED Phase 1 80 participants

Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers

Mayo Clinic

NCT04567745

COMPLETED NA 50 participants

Telehealth-enabled Integrated Palliative Care for People With Dementia

Thomas Jefferson University

NCT05524181

COMPLETED Phase 2 20 participants

Effect of Insulin Sensitizer Metformin on AD Biomarkers

University of Pennsylvania

NCT01965756

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Vascular Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CerefolinNAC® Other
1 trials
Retinal fundus photography Diagnostic test
1 trials
Telehealth Integrated Primary Care (TIPC) Other
1 trials
The BRAIN App Behavioral
1 trials
Rivastigmine Drug
1 trials
Boston Cognitive Assessment (BoCA) Diagnostic test
1 trials
No intervention. This is an observational study. Other
1 trials
ECHS AD Device Device
1 trials

US sites by state

Facility locations filed on Vascular Dementia trials. A trial with sites in several states counts in each.

Florida 4 trials
Pennsylvania 3 trials
Texas 2 trials
Vermont 1 trials
South Carolina 1 trials
Oregon 1 trials
New York 1 trials
New Mexico 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vascular Dementia page

11 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 5 Vascular Dementia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Vascular Dementia trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular Dementia condition card totals 11 registered trials; most-linked intervention CerefolinNAC®; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.